News Releases
- Chugai Selected for the “KENKO Investment for Health” for the Third Consecutive Year
- Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Results of Phase III ACHIEVE-3 Trial for Type 2 Diabetes)
- Chugai Launches “ELEVIDYS” as Japan’s First Regenerative Medical Product for Duchenne Muscular Dystrophy
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary